Showing results (491-500 of 609) with videos related to

Sort By:
Pageof 61
Implementation Science Communications|January 30, 2026
Psychometric properties of the Clinical Sustainability Assessment Tool (CSAT) short form across three research centers evaluating effectiveness and implementation of a cancer symptom surveillance and management interventionJames L Merle, Maja Kuharic, David Cella, et al.
The Journal of Allergy and Clinical Immunology|October 7, 2011
Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthmaAarti Shikotra, David F Choy, Chandra M Ohri, et al.
BMJ Open|June 29, 2022
Factors associated with cancer treatment delay: a protocol for a systematic review and meta-analysisKristin E Morrill, Rogelio Robles-Morales, Melissa Lopez-Pentecost, et al.
Implementation Science Communications|June 16, 2025
Psychometric evaluation of the NoMAD instrument in cancer care settings: assessing factorial validity, measurement invariance, and differential item functioningMaja Kuharic, James Lorenz Merle, David Cella, et al.
Transplantation Direct|January 26, 2023
Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease PatientsCary M Looney, Aaron Schroeder, Erica Tavares, et al.
International Journal of Sports Medicine|November 7, 1999
Immune response to two hours of rowing in elite female rowersD C Nieman, S L Nehlsen-Cannarella, O R Fagoaga, et al.
International Journal of Molecular Sciences|June 2, 2021
KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse ModelsJames D West, Eric D Austin, Elise M Rizzi, et al.
Medicine and Science in Sports and Exercise|August 19, 2000
Influence of carbohydrate on cytokine and phagocytic responses to 2 h of rowingD A Henson, D C Nieman, S L Nehlsen-Cannarella, et al.
Pulmonary Circulation|December 6, 2011
Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expressionEric D Austin, Swapna Menon, Anna R Hemnes, et al.
The Lancet. Oncology|December 4, 2025
Electronic health record-facilitated symptom surveillance and collaborative care intervention in oncology (E2C2): a cluster-randomised, population-level, stepped-wedge, pragmatic trialAndrea L Cheville, Jeph Herrin, Deirdre R Pachman, et al.
Pageof 61